domingo, 1 de septiembre de 2019

Are restraints on drug price increases doomed by pharma lobbying?

Are restraints on drug price increases doomed by pharma lobbying?

First Opinion

Are reasonable restraints on drug price increases doomed by pharma lobbying?

By ALFRED ENGELBERG


ADOBE
Drug price increases have been on a runaway upward trend. A bill to cap prices based on inflation could stop that, but likely won't survive pharma lobbying.

No hay comentarios:

Publicar un comentario